During the past decade, Centre Hospitalier Victor Dupouy conducted 95 clinical trials. In the 10-year time frame, 95 clinical trials started and 9 clinical trials were completed, i.e. on average, 9.5% percent of trials that started reached the finish line to date. In the past 5 years, 47 clinical trials started and 6 clinical trials were completed. i.e. 12.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier Victor Dupouy" #1 sponsor was "Nantes University Hospital" with 9 trials, followed by "Federation Francophone de Cancerologie Digestive" with 7 trials sponsored, "Groupe Francophone des Myelodysplasies" with 7 trials sponsored, "The Lymphoma Academic Research Organisation" with 6 trials sponsored and "GERCOR - Multidisciplinary Oncology Cooperative Group" with 6 trials sponsored. Other sponsors include 112 different institutions and companies that sponsored additional 72 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier Victor Dupouy" #1 collaborator was "Ministry of Health, France" with 7 trials as a collaborator, "University Hospital, Tours" with 5 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator, "Celgene" with 3 trials as a collaborator and "Janssen-Cilag Ltd." with 3 trials as a collaborator. Other collaborators include 92 different institutions and companies that were collaborators in the rest 94 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier Victor Dupouy" are "Multiple Myeloma" (9 trials), "COVID-19" (6 trials), "Acute Myeloid Leukemia" (5 trials), "Breast Cancer" (5 trials) and "Covid19" (4 trials). Many other conditions were trialed in "Centre Hospitalier Victor Dupouy" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier Victor Dupouy" are "Drug" (87 trials), "Other" (32 trials), "Procedure" (12 trials), "Device" (9 trials) and "Biological" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Cyclophosphamide" (5 trials), "Rituximab" (4 trials), "Endotracheal tubes allowing SSD" (3 trials) and "Endotracheal tubes not allowing SSD" (3 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier Victor Dupouy" are 141 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centre Hospitalier Victor Dupouy". undefined are not yet recruiting, 27 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 81 completed trials in Centre Hospitalier Victor Dupouy, 1 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier Victor Dupouy, 6 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 29 trials that are defined as “Not Applicable".

Centre Hospitalier Victor Dupouy has several departments that took part in Clinical trials: "CH Argenteuil - Service de Réanimation" - 2 trials